Makoto Hiramoto

470 total citations
14 papers, 400 citations indexed

About

Makoto Hiramoto is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Makoto Hiramoto has authored 14 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Makoto Hiramoto's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Acute Ischemic Stroke Management (4 papers) and Blood properties and coagulation (3 papers). Makoto Hiramoto is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Acute Ischemic Stroke Management (4 papers) and Blood properties and coagulation (3 papers). Makoto Hiramoto collaborates with scholars based in Japan and United States. Makoto Hiramoto's co-authors include Hidemi Yoshida, Shigeru TAKAMATSU, Kei Satoh, Tadaatsu Imaizumi, K. Satoh, Yoko KAWAMURA, Yōko Kawamura, Masayuki Koyama, Shota Mizuno and Motomichi Koyama and has published in prestigious journals such as Journal of Clinical Investigation, Stroke and Journal of the American Geriatrics Society.

In The Last Decade

Makoto Hiramoto

14 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Makoto Hiramoto Japan	10	102	89	88	73	58	14	400
E. Jarosch Austria	10	78 0.8×	76 0.9×	56 0.6×	55 0.8×	32 0.6×	26	406
Noboru Yoshimine Japan	10	95 0.9×	85 1.0×	47 0.5×	51 0.7×	78 1.3×	38	385
M. McLaren United Kingdom	12	126 1.2×	72 0.8×	100 1.1×	45 0.6×	71 1.2×	19	459
J.L. Paul France	11	182 1.8×	113 1.3×	49 0.6×	45 0.6×	135 2.3×	18	570
Yoshifumi Okura Japan	9	106 1.0×	117 1.3×	67 0.8×	35 0.5×	94 1.6×	22	336
Rajesh K. Davda United States	8	78 0.8×	105 1.2×	181 2.1×	103 1.4×	69 1.2×	12	556
Yoshinori Takajo Japan	9	85 0.8×	55 0.6×	191 2.2×	71 1.0×	45 0.8×	11	444
Kiyoko Matsui Japan	4	73 0.7×	53 0.6×	92 1.0×	118 1.6×	38 0.7×	5	425
Daniel T. Price United States	5	104 1.0×	113 1.3×	204 2.3×	89 1.2×	66 1.1×	6	702
Jorge Plutzky United States	5	99 1.0×	141 1.6×	88 1.0×	131 1.8×	72 1.2×	5	437

Countries citing papers authored by Makoto Hiramoto

Since Specialization

Citations

This map shows the geographic impact of Makoto Hiramoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Hiramoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Hiramoto more than expected).

Fields of papers citing papers by Makoto Hiramoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Hiramoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Hiramoto. The network helps show where Makoto Hiramoto may publish in the future.

Co-authorship network of co-authors of Makoto Hiramoto

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Hiramoto. A scholar is included among the top collaborators of Makoto Hiramoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Hiramoto. Makoto Hiramoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Yoshida, Hidemi, et al.. (1998). A mutation in plasma platelet-activating factor acetylhydrolase (Val279Phe) is a genetic risk factor for cerebral hemorrhage but not for hypertension.. PubMed. 80(3). 372–5. 19 indexed citations

Hiramoto, Makoto, et al.. (1997). A Mutation in Plasma Platelet-Activating Factor Acetylhydrolase (Val ²⁷⁹ →Phe) is a Genetic Risk Factor for Stroke. Stroke. 28(12). 2417–2420. 118 indexed citations

Yoshida, Hidemi, Kei Satoh, Masayuki Koyama, Makoto Hiramoto, & Shigeru TAKAMATSU. (1996). Deficiency of plasma platelet-activating factor acetylhydrolase: Roles of blood cells. American Journal of Hematology. 53(3). 158–164. 15 indexed citations

TAKAMATSU, Shigeru, K. Satoh, Tadaatsu Imaizumi, et al.. (1995). Effects on Health of Dietary Supplementation with 100 mg d-α-Tocopheryl Acetate, Daily for 6 Years. Journal of International Medical Research. 23(5). 342–357. 24 indexed citations

Yoshida, Hidemi, Kimihiko Satoh, H. Ishida, et al.. (1994). Density-associated changes in platelet-activating factor acetylhydrolase activity and membrane fluidity of human erythrocytes. Annals of Hematology. 69(3). 139–145. 8 indexed citations

Satoh, Kei, et al.. (1994). Pyrazolopyridine Derivative Acts as a Novel Cyclooxygenase Inhibitor: Antiplatelet Effect in Aged Patients with Ischemic Stroke. Journal of the American Geriatrics Society. 42(6). 639–642. 4 indexed citations

Satoh, Kimihiko, Hisashi Yoshida, Misaki Koyama, Makoto Hiramoto, & Shigeru TAKAMATSU. (1994). High-density lipoprotein inhibits the production of platelet-activating factor acetylhydrolase by HEPG2 cells. Pathophysiology. 1. 431–431. 6 indexed citations

Yoshida, Hidemi, et al.. (1992). Participation of serum albumin and LDL-cholesterol in impaired blood cell-filterability affected by white blood cells in patients with cerebral thrombosis. Scandinavian Journal of Clinical and Laboratory Investigation. 52(7). 641–646. 3 indexed citations

Yoshida, Hidemi, et al.. (1992). Platelet-activating factor acetylhydrolase activity in red blood cell-stroma from patients with cerebral thrombosis. Acta Neurologica Scandinavica. 86(2). 199–203. 12 indexed citations

10.

Satoh, K., et al.. (1992). Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. Acta Neurologica Scandinavica. 85(2). 122–127. 38 indexed citations

11.

Satoh, K., et al.. (1991). Plasma 11-dehydrothromboxane B₂: a reliable indicator of platelet hyperfunction in patients with ischemic stroke. Acta Neurologica Scandinavica. 83(2). 99–102. 9 indexed citations

12.

Satoh, Kei, et al.. (1991). Effect of cigarette smoking on the levels of platelet-activating factor-like lipid(s) in plasma lipoproteins. Atherosclerosis. 87(1). 47–55. 52 indexed citations

13.

Satoh, K., et al.. (1991). Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.. Journal of Clinical Investigation. 87(2). 476–481. 65 indexed citations

14.

Imaizumi, Tadaatsu, Kei Satoh, Hidemi Yoshida, et al.. (1990). Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Heart and Vessels. 5(2). 81–86. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact